Prostate cancer link to vasectomy is weak
Contraceptive technology update 19(3): 31
1998
ISSN/ISBN: 0274-726X PMID: 12293271 Document Number: 271926
Health care providers and men seeking vasectomies are still unsure about the nature of the association between vasectomy and prostate cancer. Two large cohort studies published in 1993 found increased relative risks for prostate cancer in vasectomized men of 1.56 and 1.66. However, this level of increased relative risk represents only a weak association between the procedure and cancer. Three other studies of similar design reported no such association. Several divisions of the National Institutes of Health examined the research and issued the joint statement in 1993 that providers should continue to offer vasectomy and perform the procedure, the reversal of vasectomies is unwarranted to prevent prostate cancer, and screening for prostate cancer should not be any different for men who have had a vasectomy than for those who have not. Joel Feigin, MD, associate professor of family medicine at Robert Wood Johnson Medical School in New Brunswick, NJ, and director of the Coventry No-Scalpel Vasectomy Center in Phillipsburg, NJ, recommends dealing proactively with the cancer link as a standard part of counseling. Thomas R. Pritchett, MD, a urologist on the clinical faculty of the University of Washington and the department of urology at Virginia Mason Medical Center in Seattle says that the strongest link to increased risk for prostate cancer is family history. Diet, race, and vasectomy are only weak associations. A definite link also exists between testosterone and prostate cancer, but undergoing vasectomy neither increases nor decreases a man's testosterone level.